PuraPharm Corporation Ltd
Company Profile
Business description
PuraPharm Corporation Ltd is a Hong Kong-based Chinese medicine Company. It is engaged in the research and development, production, marketing, and sale of concentrated Chinese medicine granules (CCMG) products marketed under the brand Nong's. The organization provides Chinese medical diagnostic services and operates through several segments: China CCMG, Hong Kong CCMG, Chinese healthcare products, Plantation, and Clinics. The majority of its revenue comes from the Hong Kong CCMG segment, which mainly involves the sale of CCMG products, excluding sales through self-operated clinics in Hong Kong. The group derives revenue from customers located in Hong Kong, Mainland China, and Other countries.
Contact
Wireless Centre, Phase One
Unit 201-207, 2nd Floor
Hong Kong Science Park
Pak Shek Kok, Tai Po, New Territories
Hong Kong
HKGT: +852 28401840
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
469
Stocks News & Analysis
stocks
Weekly earnings wrap: Last week’s winners & losers
stocks
Alphabet earnings: Continued momentum on cloud and search as capital expenses set to mount
stocks
Eli Lilly earnings: Revenue increases reflect global demand for oral obesity therapies
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,979.90 | 78.90 | -0.87% |
| CAC 40 | 8,238.17 | 23.99 | -0.29% |
| DAX 40 | 24,491.06 | 111.98 | -0.46% |
| Dow JONES (US) | 48,908.72 | 592.58 | -1.20% |
| FTSE 100 | 10,309.22 | 93.12 | -0.90% |
| HKSE | 26,456.53 | 428.71 | -1.59% |
| NASDAQ | 22,540.59 | 363.99 | -1.59% |
| Nikkei 225 | 53,984.74 | 166.70 | 0.31% |
| NZX 50 Index | 13,444.02 | 23.27 | -0.17% |
| S&P 500 | 6,798.40 | 84.32 | -1.23% |
| S&P/ASX 200 | 8,734.30 | 71.20 | -0.81% |
| SSE Composite Index | 4,073.75 | 2.16 | -0.05% |